A year of foot and ankle orthotic provision for adults: prospective consultations data, with patient satisfaction survey.

Objectives: To characterise 12 months' adult, foot and ankle orthotic out-patient consultations in a regional centre; and to survey patients regarding their satisfaction with services received.

Methods: Prospective survey questionnaires completed by: (1) orthotists, during consecutive clinic consultations (n=4402 representing 2494 patients); (2) all patients receiving foot or ankle orthoses (n=1469), mailed 5 weeks later. Questions included a standard foot pain item, patients' perceived usefulness of the orthosis, and satisfaction with services received.

Cardiac ventricular performance in the appropriate- for-gestational age and small-for-gestational age fetus: relation to regional cardiac non-uniformity and peripheral resistance.

Objective: To investigate the relationship between parameters of diastolic function, loading conditions and remodeling of the left ventricle in the appropriate-for-gestational age and small-for-gestational age fetus.

Methods: Two-dimensional echocardiographic left ventricular images were digitized in 24 appropriate-for-gestational age and 14 small-for-gestational age fetuses. The maximal short axis and long axis were measured.

Ciclopirox nail lacquer and podiatric practice.

Ciclopirox 8% nail lacquer has recently been approved by the US Food and Drug Administration (FDA) for the management of mild-to-moderate dermatophytic onychomycosis not involving the lunula. Previously, the agents that were approved for the treatment of dermatophytic pedal onychomycosis--griseofulvin, itraconazole, and terbinafine--were administered orally. When ciclopirox nail lacquer is used, it is recommended that the infected nail undergo debridement by a health-care professional as frequently as monthly.